Literature DB >> 10856722

Intracellular transport of bile acids.

L B Agellon1, E C Torchia.   

Abstract

Bile acids originate from the liver and are transported via bile to the intestines where they perform an important role in the absorption of lipids and lipid-soluble nutrients. Most of the bile acids are reclaimed from the terminal ileum and returned to the liver via portal blood for reuse. The transport of bile acids is vectorial in both liver and intestinal cells, originating and terminating at opposite poles. Bile acids enter through the basolateral pole in liver cells, and through the apical pole in intestinal cells. During the past decade, much has been learned about the mechanisms by which bile acids enter and exit liver and intestinal cells. By contrast, the mechanisms by which bile acids are transported across cells remain poorly understood. The current body of evidence suggests that bile acids do not traverse the cell by vesicular transport. Although a carrier-mediated mechanism is a likely alternative, only a handful of intracellular proteins capable of binding bile acids have been described. The significance of these proteins in the intracellular transport of bile acids remains to be tested.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10856722     DOI: 10.1016/s1388-1981(00)00057-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

Review 1.  Small bowel review: Normal physiology, part 1.

Authors:  Alan B R Thomson; Laurie Drozdowski; Claudiu Iordache; Ben K A Thomson; Severine Vermeire; M Tom Clandinin; Gary Wild
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

2.  Hepatic pharmacokinetics of taurocholate in the normal and cholestatic rat liver.

Authors:  Daniel Y Hung; Gerhard A Siebert; Ping Chang; Michael S Roberts
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 3.  An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.

Authors:  Kyunghee Yang; Kathleen Köck; Alexander Sedykh; Alexander Tropsha; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2013-05-07       Impact factor: 3.534

4.  Ablating L-FABP in SCP-2/SCP-x null mice impairs bile acid metabolism and biliary HDL-cholesterol secretion.

Authors:  Gregory G Martin; Barbara P Atshaves; Kerstin K Landrock; Danilo Landrock; Stephen M Storey; Philip N Howles; Ann B Kier; Friedhelm Schroeder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-02       Impact factor: 4.052

Review 5.  Bile acid transporters: structure, function, regulation and pathophysiological implications.

Authors:  Waddah A Alrefai; Ravinder K Gill
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.200

6.  Bile salts inhibit growth and induce apoptosis of culture human normal esophageal mucosal epithelial cells.

Authors:  Ru Zhang; Jun Gong; Hui Wang; Li Wang
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

7.  Bile salts inhibit growth and induce apoptosis of human esophageal cancer cell line.

Authors:  Ru Zhang; Jun Gong; Hui Wang; Li Wang
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

Review 8.  The Farnesoid X Receptor (FXR) as modulator of bile acid metabolism.

Authors:  Folkert Kuipers; Thierry Claudel; Ekkehard Sturm; Bart Staels
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

Review 9.  Bile acid transporters in health and disease.

Authors:  A Kosters; S J Karpen
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

10.  Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni.

Authors:  Jun Lin; Orhan Sahin; Linda Overbye Michel; Qijing Zhang
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.